In line with this, a study of a MAGEL2-null mouse model of PWS assessed the translational potential of hypothalamic adeno-associated virus (AAV)-BDNF gene therapy and the authors found that BDNF gene therapy improved glucose metabolism, insulin sensitivity, circulating adipokine levels, and body composition [48]. The gene discussed is MAGEL2; the disease is Prader-Willi syndrome.